Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention: Teleconference, 74915 [E6-21270]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 239 / Wednesday, December 13, 2006 / Notices
c. Collect and analyze data in order to
draw conclusions and describe key
findings that can be presented to the
mine action community, which consists
of United Nations (UN), governmental
and non-governmental organizations
(NGOs) focused on reducing the
negative impact of mines and
unexploded ordinance.
d. Develop materials and strategies for
the wide dissemination of findings from
the study. Organizations making up the
mine action community will benefit
from the ability to incorporate results
(such as what practices alleviate
negative social impacts on a
community) of the research into their
current practices.
e. Identify and understand all critical
aspects of the demining or abatement
process, which includes the proper
procedures and techniques for
demining, the distinction between
humanitarian and military demining, a
thorough understanding of international
standards for demining, and the ability
74915
to critically evaluate the quality of
demining programs and their work.
f. The work will be conducted in one
country per year for a total of five years,
depending upon available funding. The
likely countries are: Angola, Bosnia,
Colombia, Lebanon, and Nepal.
There are no costs to respondents
except their time to participate in the
survey.
Annualized Burden Hours:
Respondents
Number of
respondents
per year
Number of
responses/
respondent
Avg. burden
per response
(in hrs.)
Total annual
burden
(in hrs.)
Persons Identified Annually in each Country ..................................................
1580
1
1
1580
Dated: December 7, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–21192 Filed 12–12–06; 8:45 am]
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention: Teleconference
577–8993 and reference passcode ‘‘Public
Health’’.
As provided under 41 CFR 102–3.150(b),
the public health urgency of this agency
business requires that the meeting be held
prior to the first available date for publication
of this notice in the Federal Register.
Contact Person For More Information:
Lynn Austin, PhD, Executive Secretary,
Advisory Committee to the Director, CDC,
1600 Clifton Road, NE, M/S D–14, Atlanta,
Georgia 30333. Telephone 404–639–7000.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned Advisory
Committee meeting.
Dated: December 7, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E6–21270 Filed 12–12–06; 8:45 am]
Time and Date: 4 p.m.–5 p.m. Eastern
Standard Time, December 14, 2006.
Place: The conference call will originate at
the Centers for Disease Control and
Prevention, 1600 Clifton Road, Atlanta, GA
30333. Please see ‘‘Supplementary
Information’’ for details on accessing the
conference call.
Status: Open to the public, limited only by
the availability of telephone ports.
Purpose: The committee will provide
advice to the CDC Director on policy issues
and broad strategies that will enable CDC, the
Nation’s prevention agency, to fulfill its
mission of promoting health and quality of
life by preventing and controlling disease,
injury, and disability.
Matters To Be Discussed: The committee
will review and discuss recommendations
submitted by the Health Disparities
Subcommittee, ACD and the Ethics
Subcommittee, ACD. Agenda items are
subject to change as priorities dictate.
Supplementary Information: This
conference call is scheduled to begin at 4:00
p.m., Eastern Standard Time. To participate
in the conference call, please dial 1–888–
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
hsrobinson on PROD1PC76 with NOTICES
Centers for Disease Control and
Prevention
VerDate Aug<31>2005
21:31 Dec 12, 2006
Jkt 211001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers For Medicare & Medicaid
Services
Privacy Act of 1974; Report of New
System of Records
Department of Health and
Human Services (HHS), Centers for
Medicare & Medicaid Services (CMS).
ACTION: Notice of a new system of
records.
AGENCY:
SUMMARY: In accordance with the
requirements of the Privacy Act of 1974,
CMS is proposing to establish a new
system of records (SOR) titled
‘‘Medicare Integrated Data Repository
(IDR),’’ System No. 09–70–0571. In
December 2003, Congress passed the
Medicare Prescription Drug,
PO 00000
Frm 00020
Fmt 4703
Sfmt 4703
Improvement, and Modernization Act of
2003 (MMA) (Pub. L. 108–173), that
amends Title XVIII of the Social
Security Act (the Act) by adding Part D,
the voluntary prescription drug benefit
program.
The IDR will provide an organized
structure for reaching the data through
a consistent application of access
policies, processes and procedures,
common services, governance, and
framework. The IDR will integrate and
load data from various CMS systems
consisting of Medicare Parts A, B, C,
and D entitlement, enrollment and
utilization data. It is proposed that the
IDR will also contain demographic
information on Medicaid beneficiaries,
Medicare providers and physicians, and
employer plans that are receiving a
subsidy from CMS for providing
creditable drug coverage to their
retirees. It is through the integration of
this data with other data (e.g., historic
data, Part A and Part B data) that the
IDR will have value for quality
improvement, research on outcomes and
effectiveness of drugs, post-market
surveillance, and other analytic efforts.
The primary purpose of this system is
to establish an enterprise resource that
will provide one integrated view of all
CMS data to administer the Medicare
and Medicaid programs. Information
retrieved from this system of records
will also be disclosed to: (1) Support
regulatory, reimbursement, and policy
functions performed within the agency
or by a contractor, consultant or CMS
grantee; (2) assist another Federal or
state agency, agency of a state
government, an agency established by
state law, or its fiscal agent; (3) support
providers and suppliers of services for
administration of Title XVIII; (4) assist
third parties where the contact is
expected to have information relating to
the individual’s capacity to manage his
E:\FR\FM\13DEN1.SGM
13DEN1
]]>Agencies
[Federal Register Volume 71, Number 239 (Wednesday, December 13, 2006)]
[Notices]
[Page 74915]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-21270]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee to the Director (ACD), Centers for Disease
Control and Prevention: Teleconference
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned Advisory Committee
meeting.
Time and Date: 4 p.m.-5 p.m. Eastern Standard Time, December 14,
2006.
Place: The conference call will originate at the Centers for
Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA
30333. Please see ``Supplementary Information'' for details on
accessing the conference call.
Status: Open to the public, limited only by the availability of
telephone ports.
Purpose: The committee will provide advice to the CDC Director
on policy issues and broad strategies that will enable CDC, the
Nation's prevention agency, to fulfill its mission of promoting
health and quality of life by preventing and controlling disease,
injury, and disability.
Matters To Be Discussed: The committee will review and discuss
recommendations submitted by the Health Disparities Subcommittee,
ACD and the Ethics Subcommittee, ACD. Agenda items are subject to
change as priorities dictate.
Supplementary Information: This conference call is scheduled to
begin at 4:00 p.m., Eastern Standard Time. To participate in the
conference call, please dial 1-888-577-8993 and reference passcode
``Public Health''.
As provided under 41 CFR 102-3.150(b), the public health urgency
of this agency business requires that the meeting be held prior to
the first available date for publication of this notice in the
Federal Register.
Contact Person For More Information: Lynn Austin, PhD, Executive
Secretary, Advisory Committee to the Director, CDC, 1600 Clifton
Road, NE, M/S D-14, Atlanta, Georgia 30333. Telephone 404-639-7000.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: December 7, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E6-21270 Filed 12-12-06; 8:45 am]
BILLING CODE 4163-18-P
